Browse Studies — Arctuva

Phase 2

Platform Clinical Study for Conquering Scleroderma: A Multicenter, Double-Blind, Randomized, Placebo-Controlled, Phase 2b Platform Clinical Study to Evaluate the Safety and Efficacy of Investigational Products in Participants With Interstitial Lung Disease Secondary to Systemic Sclerosis

The goal of this clinical trial is to test efficacy of different investigational products (IPs) compared with placebo on the change from baseline to the end of…

Interstitial Lung Disease Due to Systemic DiseaseScleroderma

Estimated

~$10 – $6,250

Scleroderma Research Foundation, Inc.NCT06195072

Phase 1

Nucleoside Therapy in Patients With Telomere Biology Disorders

The goal of this clinical trial is to learn if a combination therapy of deoxycytidine (dC) plus deoxythymidine (dT) is safe in patients with telomere biology d…

Telomere Biology DisordersDyskeratosis CongenitaRevesz Syndrome+4 more

Estimated

~$10 – $8,750

Suneet AgarwalNCT06817590

Teleconsultation Approach to CTD-ILD Care Delivery in Rural UnderServed CommuniTies (TRUST Initiative)

Connective tissue disease-associated interstitial lung disease (CTD-ILD) is a rare and complex condition that affects some individuals with autoimmune disorder…

Interstitial Lung Disease Due to Systemic Disease (Disorder)Interstitial Lung Disease in Patients With Rheumatoid ArthritisInterstitial Lung Disease Due to Systemic Disease

Estimated

~$10 – $750

St. Lawrence Health SystemNCT07217093